Skip to main content
. Author manuscript; available in PMC: 2015 Jul 25.
Published in final edited form as: J Vasc Surg. 2012 Jun 12;56(1):e17–e51. doi: 10.1016/j.jvs.2012.05.054

Table 3.5.

Surveillance After Renal or Mesenteric Artery Revascularization

Indication Appropriate Use Score (1–9)
Asymptomatic
55. • Baseline surveillance (within 1 month) after revascularization A (8)
New or Worsening Symptoms After Baseline
56. • After renal or mesenteric artery revascularization A (8)
Asymptomatic or Stable Symptoms After Baseline Study, Surveillance Frequency During First Year At 3 to 5 months At 6 to 8 months At 9 to 12 months
57. • During first 12 months after endovascular revascularization I (3) U (6) U (6)
Asymptomatic or Stable Symptoms After Baseline Study, Surveillance Frequency After First Year Every 6 months Every 12 months Every 24 months or greater
58. • After first 12 months after endovascular revascularization I (3) A (7) U (5)

A = appropriate; I = inappropriate; U = uncertain.